nobiletin has been researched along with Colorectal Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Cheng, WC; Ho, CT; Ho, PY; Lin, WS; Pan, MH | 1 |
Jiang, G; Li, N; Sun, H; Yu, D; Zhang, Z | 1 |
Kawabata, K; Murakami, A; Ohigashi, H | 1 |
3 other study(ies) available for nobiletin and Colorectal Neoplasms
Article | Year |
---|---|
Regulation of Xenobiotic-Metabolizing Enzymes by 5-Demethylnobiletin and Nobiletin to Mitigate Benzo[a]pyrene-Induced DNA Damage
Topics: Animals; Benzo(a)pyrene; Colorectal Neoplasms; DNA Adducts; DNA Damage; Mice; Xenobiotics | 2023 |
Nobiletin sensitizes colorectal cancer cells to oxaliplatin by PI3K/Akt/MTOR pathway.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Drug Synergism; Flavones; HT29 Cells; Humans; Oxaliplatin; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
Nobiletin, a citrus flavonoid, down-regulates matrix metalloproteinase-7 (matrilysin) expression in HT-29 human colorectal cancer cells.
Topics: Colorectal Neoplasms; Dose-Response Relationship, Drug; Down-Regulation; Flavones; Gene Expression Profiling; HT29 Cells; Humans; Matrix Metalloproteinase 7; RNA, Messenger; Time Factors; Transcription Factor AP-1 | 2005 |